Stock listing
NYSE:GRDN Guardian Pharmacy Services, Inc. Stock
Home listing (NYSE) of Guardian Pharmacy Services, Inc.
Follow Guardian Pharmacy Services, Inc. into a list and get an email when it puts out news.
Share price · NYSE:GRDN
$46.94 USD -1.90 (-3.9%)
Close on Nov 20, 2026
- Day range
- $46.13 – $47.48 USDNov 20, 2026
- Volume
- 526,696 sharesNov 20, 2026
- Market cap
- $2.97B USDAt the close on Nov 20, 2026 · price × 63.32M shares outstanding
- 52-week range
- $26.34 – $50.80 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $23.16M USDMedian day 444,000 shares · last 3 months, Aug 20, 2026 – Nov 20, 2026

Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NYSE:GRDN · Home | $46.94 USD | -1.90 (-3.9%) | 526,696 | $46.40 | $47.48 | $46.13 | $48.84 | Close on Nov 20, 2026 |
Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · NYSE:GRDN · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $46.94 | -1.90 | -3.9% | $46.40 | $47.48 | $46.13 | 526,696 | |
| $48.84 | -1.49 | -3.0% | $50.15 | $50.80 | $48.74 | 451,689 | |
| $50.33 | +0.90 | +1.8% | $49.82 | $50.80 | $49.20 | 333,489 | |
| $49.43 | -0.09 | -0.2% | $49.43 | $50.17 | $48.78 | 369,715 | |
| $49.52 | +0.14 | +0.3% | $49.61 | $50.06 | $49.11 | 339,068 | |
| $49.38 | -0.60 | -1.2% | $50.06 | $50.28 | $48.79 | 388,600 | |
| $49.98 | +0.13 | +0.3% | $49.75 | $50.59 | $49.01 | 662,589 | |
| $49.85 | +2.83 | +6.0% | $46.67 | $50.17 | $46.59 | 1,184,489 | |
| $47.02 | +4.63 | +10.9% | $42.75 | $47.02 | $41.53 | 932,559 | |
| $42.39 | +2.52 | +6.3% | $43.41 | $43.41 | $40.22 | 1,085,425 | |
| $39.87 | -2.22 | -5.3% | $42.15 | $42.53 | $39.45 | 701,199 | |
| $42.09 | +1.22 | +3.0% | $41.47 | $43.09 | $41.36 | 658,225 | |
| $40.87 | +0.87 | +2.2% | $40.00 | $40.96 | $39.79 | 496,551 | |
| $40.00 | -0.69 | -1.7% | $40.50 | $40.57 | $39.71 | 410,298 | |
| $40.69 | +0.24 | +0.6% | $40.98 | $41.37 | $40.26 | 318,971 | |
| $40.45 | +0.12 | +0.3% | $40.78 | $41.07 | $40.16 | 207,976 | |
| $40.33 | +0.77 | +1.9% | $39.29 | $40.48 | $39.06 | 235,448 | |
| $39.56 | +0.37 | +0.9% | $39.24 | $39.93 | $38.89 | 357,113 | |
| $39.19 | -0.25 | -0.6% | $39.74 | $40.17 | $38.87 | 212,144 | |
| $39.44 | -0.15 | -0.4% | $39.41 | $39.63 | $39.02 | 242,065 | |
| $39.59 | +0.61 | +1.6% | $39.38 | $39.97 | $39.27 | 252,888 | |
| $38.98 | -2.89 | -6.9% | $41.58 | $41.99 | $38.91 | 429,333 | |
| $41.87 | +1.73 | +4.3% | $40.39 | $42.26 | $39.67 | 591,410 | |
| $40.14 | +0.67 | +1.7% | $39.71 | $40.40 | $39.41 | 378,646 | |
| $39.47 | -0.21 | -0.5% | $39.68 | $39.86 | $39.07 | 426,000 | |
| $39.68 | -0.90 | -2.2% | $40.87 | $41.22 | $39.26 | 444,000 | |
| $40.58 | +0.77 | +1.9% | $39.56 | $40.59 | $39.30 | 390,700 | |
| $39.81 | -0.66 | -1.6% | $40.77 | $40.77 | $39.63 | 300,400 | |
| $40.47 | -0.81 | -2.0% | $40.61 | $40.61 | $39.13 | 733,200 | |
| $41.28 | -0.32 | -0.8% | $41.43 | $41.48 | $40.67 | 397,500 | |
| $41.60 | +0.92 | +2.3% | $40.79 | $41.80 | $40.19 | 574,100 | |
| $40.68 | -0.52 | -1.3% | $40.77 | $41.98 | $40.35 | 388,300 | |
| $41.20 | -0.90 | -2.1% | $42.30 | $42.95 | $40.80 | 388,632 | |
| $42.10 | -0.28 | -0.7% | $42.60 | $42.74 | $42.08 | 276,030 | |
| $42.38 | +1.54 | +3.8% | $41.10 | $42.44 | $40.86 | 542,300 | |
| $40.84 | +0.06 | +0.1% | $40.66 | $41.25 | $40.04 | 498,100 | |
| $40.78 | +0.10 | +0.2% | $41.23 | $41.89 | $40.54 | 540,200 | |
| $40.68 | -0.06 | -0.1% | $40.48 | $40.89 | $40.19 | 488,200 | |
| $40.74 | -0.47 | -1.1% | $41.12 | $42.42 | $40.09 | 621,500 | |
| $41.21 | -0.58 | -1.4% | $41.70 | $42.34 | $41.19 | 720,600 | |
| $41.79 | -1.47 | -3.4% | $43.09 | $43.82 | $41.50 | 494,400 | |
| $43.26 | -1.41 | -3.2% | $44.65 | $45.07 | $43.17 | 440,800 | |
| $44.67 | +0.51 | +1.2% | $44.36 | $45.37 | $44.36 | 396,900 | |
| $44.16 | -0.83 | -1.8% | $45.14 | $45.14 | $43.34 | 570,300 | |
| $44.99 | -0.06 | -0.1% | $45.01 | $45.64 | $44.24 | 3,205,600 | |
| $45.05 | -1.47 | -3.2% | $46.53 | $46.97 | $45.02 | 604,000 | |
| $46.52 | -1.48 | -3.1% | $47.57 | $48.33 | $45.19 | 836,800 | |
| $48.00 | +1.51 | +3.2% | $46.00 | $48.14 | $46.00 | 719,482 | |
| $46.49 | +2.85 | +6.5% | $43.50 | $46.82 | $43.50 | 925,866 | |
| $43.64 | -0.19 | -0.4% | $44.06 | $44.76 | $43.39 | 923,200 | |
| $43.83 | +0.44 | +1.0% | $43.23 | $44.55 | $42.87 | 698,600 | |
| $43.39 | +0.94 | +2.2% | $42.31 | $43.74 | $41.99 | 518,500 | |
| $42.45 | +1.68 | +4.1% | $40.61 | $42.63 | $40.01 | 653,108 | |
| $40.77 | +0.64 | +1.6% | $40.13 | $40.95 | $39.98 | 418,400 | |
| $40.13 | +1.09 | +2.8% | $39.41 | $40.15 | $38.04 | 652,700 | |
| $39.04 | +0.17 | +0.4% | $38.87 | $40.08 | $38.66 | 469,700 | |
| $38.87 | +1.78 | +4.8% | $37.06 | $39.34 | $35.90 | 537,300 | |
| $37.09 | +0.03 | +0.1% | $36.97 | $37.44 | $36.65 | 299,000 | |
| $37.06 | -0.27 | -0.7% | $37.52 | $37.61 | $36.84 | 412,400 | |
| $37.33 | -0.15 | -0.4% | $37.40 | $37.74 | $36.86 | 219,100 | |
| $37.48 | +0.18 | +0.5% | $37.47 | $38.13 | $37.22 | 284,600 | |
| $37.30 | -0.40 | -1.1% | $37.88 | $37.88 | $36.79 | 321,615 | |
| $37.70 | -0.23 | -0.6% | $38.09 | $38.36 | $37.34 | 349,302 | |
| $37.93 | +0.45 | +1.2% | $37.55 | $38.12 | $36.90 | 396,500 | |
| $37.48 | -0.49 | -1.3% | $37.51 | $38.00 | $37.24 | 214,900 |
- Ticker
- NYSE:GRDN
- Asset type
- Stock
- Sector
- Health care
- Industry
- Health care services
- Exchange
- NYSE
- Currency
- USD
What changed lately
Latest news release · Nov 16, 2026
Guardian Pharmacy Services, Inc. to Participate in Upcoming Citi Annual Global Healthcare Conference
Latest earnings call · Aug 6, 2026
Guardian Pharmacy Services (NYSE:GRDN) Q2 2026 Earnings Call
Replay and transcript
Latest deck · October 2026
Investor Presentation (October 2026)
Investor deck · 29 slides
Latest news
Guardian Pharmacy Services, Inc. to Participate in Upcoming Citi Annual Global Healthcare Conference
Nov 16, 2026
Closed $50.33 (+1.8%) on Nov 17, 2026
Guardian Pharmacy Services Reports Third Quarter 2026 Financial Results; Raises Full-Year Guidance
Nov 5, 2026
Closed $42.39 (+6.3%) on Nov 6, 2026
Guardian Pharmacy Services, Inc. to Participate in Upcoming Stephens Investment Conference
Nov 2, 2026
Closed $40.87 (+2.2%) on Nov 3, 2026
Guardian Pharmacy Services Acquires Van’s Institutional Pharmacy, Expanding Footprint in Tennessee and Kentucky
Nov 2, 2026
Closed $40.87 (+2.2%) on Nov 3, 2026
Guardian Pharmacy Services, Inc. to Report Third Quarter 2026 Financial Results and Host Conference Call
Oct 21, 2026
Closed $39.59 (+1.6%) on Oct 22, 2026
Guardian Pharmacy Services Acquires Assets of Tennessee-Based Nautilus Pharmacy
Sep 1, 2026
Closed $39.04 (+0.4%) on Sep 2, 2026
Guardian Pharmacy Services, Inc., to Participate in Upcoming Jefferies Healthcare Services Investor Conference
Aug 19, 2026
Closed $37.48 (-1.3%) on Aug 20, 2026
Guardian Pharmacy Services Reports Second Quarter 2026 Financial Results; Raises Full-Year Guidance
Aug 6, 2026
Closed $43.83 (+11.0%) on Aug 7, 2026
Guardian Pharmacy Services Opens Long-Term Care Pharmacy in Lexington, Kentucky
Aug 3, 2026
Closed $40.81 (+3.2%) on Aug 3, 2026
Guardian Pharmacy Services, Inc. to Report Second Quarter 2026 Financial Results and Host Conference Call
Jul 15, 2026
Closed $40.37 (+1.0%) on Jul 16, 2026
Guardian Pharmacy Services, Inc. on 6ix
- Sector
- Health care
- Industry
- Health care services
- News releases
- 28 in the last 12 months · 49 in all · newest Nov 16, 2026 · oldest 2025
- Calls
- 7 calls with a replay · 7 with a transcript · latest Aug 6, 2026
- Decks
- 8 decks · latest October 2026
Where Guardian Pharmacy Services, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NYSE:GRDN · Home listing · This page | NYSE | United States | USD |
| BOATS:GRDN | BOATS | United States | USD |
Valuation
P/E 39.8× against a median of 29.3×: 7th lowest of 8 Health care services companies shown. Statements: 4 quarters to Sep 30, 2026 · price Nov 20, 2026
- Enterprise value
- $2.86B USD
- P/E
- 39.8×
- EV/sales
- 2.0×
- EV/EBITDA
- 24.3×
- Price/book
- 10.6×
- Gross margin
- 22.4%
- Operating margin
- 6.5%
- Net margin
- 5.1%
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.70
Health care services: the 10 companies nearest in size, of 419 on 6ix with figures. Size in US dollars.
| Company | Mkt cap | EV | P/E | EV/Sales | EV/EBITDA | P/B | Net mgn | Debt/Eq | Beta |
|---|---|---|---|---|---|---|---|---|---|
| Guardian Pharmacy Services, Inc. · NYSE:GRDN | US$2.97B | US$2.86B | 39.8× | 2.0× | 24.3× | 10.6× | 5.1% | 0.0× | 0.70 |
| Surgery Partners, Inc. · NASDAQ:SGRY | US$3.50B | US$6.21B | n/a | 1.9× | 11.5× | 2.1× | −2.6% | 1.8× | 0.94 |
| Hims & Hers Health, Inc. · NYSE:HIMS | US$3.30B | US$4.15B | n/a | 1.4× | n/a | 9.3× | −6.7% | 4.4× | 2.64 |
| Acadia Healthcare Company, Inc. · NASDAQ:ACHC | US$3.22B | US$5.41B | n/a | 1.6× | 10.1× | 1.6× | −33.1% | 1.2× | 0.82 |
| Privia Health Group, Inc. · NASDAQ:PRVA | US$3.20B | US$2.76B | 92.1× | 1.1× | 43.3× | 3.9× | 1.4% | 0.0× | 0.23 |
| National HealthCare Corporation · AMEX:NHC | US$2.99B | US$3.27B | 26.1× | 2.1× | 16.0× | 2.7× | 7.2% | 0.5× | 0.37 |
| Inventurus Knowledge Solutions Limited · NSE:IKS | US$2.97B | US$2.97B | 36.0× | 8.2× | 23.3× | 9.8× | 22.8% | 0.0× | n/a |
| Sinopharm Group Co., Ltd. Class H · HKEX:1099 | US$2.88B | US$8.80B | 2.7× | 0.1× | 2.9× | 0.2× | 1.2% | 0.9× | n/a |
| KPJ Healthcare Bhd. · MYX:KPJ | US$2.85B | US$3.53B | 29.3× | 3.2× | 14.2× | 3.9× | 8.9% | 1.3× | n/a |
| Progyny, Inc. · NASDAQ:PGNY | US$2.74B | US$2.57B | 30.1× | 1.9× | 19.2× | 6.6× | 6.8% | 0.1× | -0.09 |
| Pediatrix Medical Group, Inc. · NYSE:MD | US$2.46B | US$2.21B | 16.4× | 1.1× | 9.3× | 2.9× | 7.7% | 0.2× | 0.34 |
| Median of the others | US$2.98B | US$3.40B | 29.3× | 1.7× | 14.2× | 3.4× | 4.1% | 0.7× | 0.37 |
Forecasts
6 strong buy · 1 buy · Analysts' consensus from EODHD, read Nov 20, 2026. Not 6ix's view and not investment advice.
- Price target
- 51.29 USD · Analysts' mean
- EPS, year to Dec 2026
- 1.36 · 7 analysts
- Revenue, year to Dec 2026
- 1.45B · 7 analysts
Team and board
| Officer | Role |
|---|---|
| Fred Burke | President & CEO |
| Will Mudd | Chief Financial Officer |
| Matthew Hopp | Regional Pharmacy President, Georgia |
| Mike Flint | Regional Pharmacy President, Wisconsin |
| Nathan Stauffer | Regional Pharmacy President, Michigan |
| Ron Belville | Regional Pharmacy President, California |
| Tom Mullaney | Regional Pharmacy President, Ohio |
| David Morris | Chief Operating Officer |
| Doug Towns | SVP, General Counsel & Senior Compliance Officer |
| Bob Weir | SVP, Operations & Regulatory Support |
| Chris Crisafulli | SVP, Payor and Industry Strategy |
| David Brown | SVP, Central Region |
| David Martin | SVP, Technology, Data & Senior Security Officer |
| Jeff Tuch | SVP, Purchasing & Pricing Analytics |
| John Saliba | SVP, West Region |
| Khristy McClelland | SVP, Southeast Region |
| Marybeth Terry | SVP, East Region |
| Michael Counts | SVP, Midwest Region |
| Rich Eakins | SVP, Sales, Account Management, Marketing |
| Rockford Anderson | SVP, North Central Region |
| Tanner Corsini | SVP, South Central Region |
Events
Calls
| Call | When | Status |
|---|---|---|
| Guardian Pharmacy Services (NYSE:GRDN) Q2 2026 Earnings Call | Thu, Aug 06, 2026 · 4:30 PM ET | Replay |
| Guardian Pharmacy Services (NYSE:GRDN) Q1 2026 Earnings Call | Wed, May 06, 2026 · 4:30 PM ET | Replay |
| Guardian Pharmacy Services (NYSE:GRDN) Q4 2025 Earnings Call | Wed, Mar 11, 2026 · 4:30 PM ET | Replay |
| Guardian Pharmacy Services (NYSE:GRDN) Q3 2025 Earnings Call | Mon, Nov 10, 2025 · 4:30 PM ET | Replay |
| Guardian Pharmacy Services (NYSE:GRDN) Q2 2025 Earnings Call | Mon, Aug 11, 2025 · 4:30 PM ET | Replay |
| Guardian Pharmacy Services (NYSE:GRDN) Q1 2025 Earnings Call | Mon, May 12, 2025 · 4:30 PM ET | Replay |
| Guardian Pharmacy Services (NYSE:GRDN) Q4 2024 Earnings Call | Wed, Mar 26, 2025 · 4:30 PM ET | Replay |
Results days
| Quarter | Results | Share move |
|---|---|---|
| Q3 2026 | Nov 5, 2026 · After close | +6.3% |
| Q2 2026 | Aug 6, 2026 · After close | +11.1% |
| Q1 2026 | May 6, 2026 · After close | −0.8% |
| Q4 2025 | Mar 11, 2026 | −1.1% |
| Q3 2025 | Nov 10, 2025 · After close | +5.0% |
| Q2 2025 | Aug 11, 2025 · After close | +13.8% |
| Q1 2025 | May 12, 2025 · After close | −4.0% |
| Q4 2024 | Mar 27, 2025 | −0.4% |
| Q3 2024 | Nov 12, 2024 · After close | −10.7% |
| Q2 2024 | Aug 28, 2024 |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (October 2026) | Investor deck | 29 slides | October 2026 |
| Q2 2026 Earnings Presentation | Earnings | 27 slides | Aug 6, 2026 |
| Investor Presentation (March 2026) | Investor deck | 28 slides | March 2026 |
| J.P. Morgan Healthcare Conference 2026 | Conference | 34 slides | January 2026 |
| Investor Presentation (September 2025) | Investor deck | 40 slides | Sep 18, 2025 |
| Q1 2025 Earnings Presentation | Earnings | 26 slides | May 12, 2025 |
| FY2024 Earnings Presentation | Earnings | 21 slides | Mar 3, 2025 |
| Raymond James & Associates' 46th Annual Institutional Investors Conference 2025 | Conference | 21 slides | Mar 3, 2025 |
IPO
Priced at US$14.00 a share on Sep 25, 2024.
- Price
- US$14.00 a share
- Shares offered
- 8,000,000 shares of Class A common stock
- Offering size
- US$112 million
- Underwriters' option
- Up to 1,200,000 more shares
- Underwriters
- Raymond James, Stephens Inc., Truist Securities · In the order on the cover
- Shares delivered
- On or about Sep 27, 2024
Steps
| Step | When |
|---|---|
| Draft sent to the SEC in confidence | Feb 13, 2020 |
| Filed publicly | Oct 3, 2023 |
| Amended twice | Newest Sep 16, 2024 |
| Shares registered with an exchange | Sep 25, 2024 |
| Declared effective by the SEC | Sep 25, 2024 |
| Final prospectus, with the price | Sep 26, 2024 |
Filings
| Filing | Filed |
|---|---|
| 424B4 · Prospectus | Sep 26, 2024 |
| S-1MEF · Registration of more shares for the same offering | Sep 26, 2024 |
| EFFECT · Notice that a registration is effective | Sep 25, 2024 |
| CERT · Exchange's certificate of listing | Sep 25, 2024 |
| 8-A12B · Registration of shares for listing on an exchange | Sep 25, 2024 |
| CORRESP · Letter to the SEC | Sep 23, 2024 |
| CORRESP · Letter to the SEC | Sep 23, 2024 |
| S-1/A · Registration statement, amended | Sep 16, 2024 |
| CORRESP · Letter to the SEC | Sep 6, 2024 |
| UPLOAD · Letter from the SEC | Sep 3, 2024 |
All 29 filings
| Filing | Filed |
|---|---|
| S-1/A · Registration statement, amended | Aug 22, 2024 |
| UPLOAD · Letter from the SEC | Jul 10, 2024 |
| S-1 · Registration statement | Oct 3, 2023 |
| DRSLTR · Letter to the SEC with a draft | Aug 23, 2023 |
| DRS/A · Draft registration statement, amended | Aug 23, 2023 |
| UPLOAD · Letter from the SEC | Jul 21, 2023 |
| DRSLTR · Letter to the SEC with a draft | Jul 12, 2023 |
| DRS/A · Draft registration statement, amended | Jul 12, 2023 |
| UPLOAD · Letter from the SEC | Jun 9, 2023 |
| DRS/A · Draft registration statement, amended | May 12, 2023 |
| DRS/A · Draft registration statement, amended | Nov 22, 2021 |
| DRS/A · Draft registration statement, amended | Jul 23, 2021 |
| DRSLTR · Letter to the SEC with a draft | Jul 22, 2021 |
| DRSLTR · Letter to the SEC with a draft | Jul 20, 2021 |
| UPLOAD · Letter from the SEC | Apr 14, 2020 |
| DRSLTR · Letter to the SEC with a draft | Apr 3, 2020 |
| DRS/A · Draft registration statement, amended | Apr 3, 2020 |
| UPLOAD · Letter from the SEC | Mar 11, 2020 |
| DRS · Draft registration statement | Feb 13, 2020 |
Open IPO · From the cover of the final prospectus (424B4) filed Sep 26, 2024
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.45B | 1.23B | 1.05B | 908.9M | 792.1M | 736.0M | 698.3M | 600.4M |
| Cost of revenue | 1.16B | 984.0M | 837.9M | 723.0M | 630.8M | 589.0M | 554.8M | 477.3M |
| Gross profit | 292.7M | 244.4M | 208.3M | 185.9M | 161.3M | 147.0M | 143.5M | 123.0M |
| Selling, general and administrative | 220.0M | 307.3M | 167.4M | 3.38M | 13.0M | 102.5M | ||
| Operating income | 72.7M | -62.9M | 40.9M | 52.0M | 30.1M | 32.1M | 34.1M | 25.9M |
| Depreciation and amortization | 22.3M | 19.8M | 18.2M | 16.6M | 16.5M | 17.3M | 15.8M | 13.1M |
| EBITDA | 95.0M | -43.1M | 59.2M | 68.6M | 46.7M | 49.3M | 49.9M | 39.1M |
| Interest expense | 665.0K | 3.28M | 2.86M | 1.93M | 1.64M | 2.16M | 2.25M | 1.90M |
| Income before tax | 73.4M | -66.5M | 37.7M | 49.7M | 28.3M | 29.7M | 31.4M | 23.3M |
| Income tax | 24.5M | 4.56M | ||||||
| Net income | 49.2M | -110.0M | 23.9M | 35.4M | 16.3M | 19.9M | 21.7M | 14.7M |
| Earnings per share, basic | 0.78 | -1.77 | 0.39 | 0.58 | 0.27 | 0.33 | 0.36 | 0.24 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | 65.6M | 4.66M | 752.0K | 607.0K | 15.0M | 6.45M | 275.0K | 2.25M |
| Receivables | 101.6M | 97.2M | 77.3M | 67.8M | 55.2M | 45.8M | 54.2M | 47.7M |
| Inventory | 43.4M | 40.5M | 36.7M | 41.4M | 33.1M | 31.9M | 30.9M | 27.5M |
| Current assets | 221.6M | 152.0M | 129.6M | 120.0M | 111.9M | 93.8M | 90.1M | 81.2M |
| Property, plant and equipment | 55.5M | 49.9M | ||||||
| Goodwill | 79.7M | 69.3M | 56.0M | 56.0M | 54.6M | 52.5M | 46.3M | 47.8M |
| Total assets | 412.7M | 320.8M | 271.2M | 256.1M | 235.8M | 217.9M | 196.5M | 181.8M |
| Accounts payable | 116.2M | 102.4M | 85.6M | 78.1M | 64.6M | 53.4M | 54.9M | 47.5M |
| Current liabilities | 160.7M | 144.1M | 138.0M | 112.0M | 111.5M | 86.4M | 90.2M | 65.3M |
| Long-term debt | 19.0M | 23.0M | 27.0M | 30.7M | ||||
| Total debt | 0 | 0 | 69.2M | 63.0M | 55.0M | 58.8M | 57.1M | 43.7M |
| Total liabilities | 194.7M | 170.8M | 211.3M | 180.2M | 182.5M | 150.8M | 139.5M | 113.8M |
| Shareholders' equity | 217.9M | 150.0M | 28.2M | 42.7M | 23.9M | 38.5M | 57.0M | 34.0M |
| Shares outstanding | 63.3M | 62.0M | 60.8M | 60.8M | 60.8M | 60.8M | 60.8M | 60.8M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | 100.3M | 58.0M | 70.8M | 48.5M | 58.5M | 52.6M | 56.2M | 43.7M |
| Capital spending | -13.4M | -14.7M | -14.6M | -16.8M | -9.28M | -8.34M | -14.5M | -10.0M |
| Free cash flow | 86.8M | 43.3M | 56.3M | 31.8M | 49.2M | 44.3M | 41.6M | 33.7M |
| Cash from investing | -32.2M | -30.4M | -13.4M | -17.9M | -13.1M | -12.2M | -16.6M | -20.7M |
| Cash from financing | -7.07M | -23.6M | -57.2M | -45.0M | -36.8M | -34.3M | -41.5M | -21.1M |
| Dividends paid | 0 | -35.8M | -38.4M | -30.8M | -17.4M | -10.8M | -34.3M | -28.0M |
| Share buybacks | -29.0M | -55.2M | 0 | |||||
| Change in cash | 61.0M | 3.91M | 145.0K | -14.4M | 8.56M | 6.17M | -1.98M | 1.85M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4/A · Change in ownership, amended | Nov 19, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Nov 18, 2026 | Insider trade | SEC |
| 144 · Notice of proposed sale | Nov 17, 2026 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 5, 2026 | Quarterly report | SEC |
| 8-K · Current report | Nov 5, 2026 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 5, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Sep 28, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Sep 28, 2026 | Insider trade | SEC |
| 8-K · Current report | Sep 10, 2026 | Current report | SEC |
| 10-Q · Quarterly report | Aug 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | Aug 6, 2026 | Results | SEC |
| 8-K · Current report | Jun 22, 2026 | Management or board change | SEC |
| 8-K · Current report | May 28, 2026 | Material contract | SEC |
| 4 · Change in ownership | May 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 7, 2026 | Insider trade | SEC |
| 4 · Change in ownership | May 7, 2026 | Insider trade | SEC |
| 8-K · Current report | May 7, 2026 | Meeting outcome | SEC |
| S-8 · Registration statement for employee plans | May 6, 2026 | Offer document | SEC |
| S-3ASR · Registration statement | May 6, 2026 | Offer document | SEC |
| 10-Q · Quarterly report | May 6, 2026 | Quarterly report | SEC |
| 8-K · Current report | May 6, 2026 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | May 6, 2026 | Big-stake notice | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 31, 2026 | Insider trade | SEC |
| DEFA14A · Additional proxy material | Mar 26, 2026 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 26, 2026 | Meeting notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Mar 24, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 24, 2026 | Insider trade | SEC |
| 8-K · Current report | Mar 23, 2026 | Material contract | SEC |
| 424B5 · Prospectus | Mar 19, 2026 | Offer document | SEC |
| S-3MEF | Mar 19, 2026 | Other filings | SEC |
| 424B5 · Prospectus | Mar 18, 2026 | Offer document | SEC |
| 10-K · Annual report | Mar 11, 2026 | Annual report | SEC |
| 8-K · Current report | Mar 11, 2026 | Results | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Mar 3, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Feb 13, 2026 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 10, 2026 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 21, 2026 | Big-stake notice | SEC |
| 8-K · Current report | Jan 13, 2026 | Results | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 8, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Dec 5, 2025 | Insider trade | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Nov 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 12, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 10, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 10, 2025 | Results | SEC |
| 424B3 · Prospectus | Nov 4, 2025 | Offer document | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 17, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Oct 14, 2025 | Current report | SEC |
| S-3 · Registration statement | Oct 14, 2025 | Offer document | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Sep 30, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 30, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 30, 2025 | Insider trade | SEC |
| 8-K · Current report | Sep 18, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 12, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 11, 2025 | Quarterly report | SEC |
| 8-K · Current report | Aug 11, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 5, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 5, 2025 | Big-stake notice | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | Jul 29, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 29, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jul 17, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Jun 18, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jun 6, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jun 6, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jun 6, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| SCHEDULE 13D/A · Big-stake notice, amended | May 29, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | May 29, 2025 | Insider trade | SEC |
| 424B4 · Prospectus | May 23, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | May 23, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 20, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 20, 2025 | Other filings | SEC |
| S-1 · Registration statement | May 20, 2025 | Offer document | SEC |
| 8-K · Current report | May 20, 2025 | Material contract | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 4 · Change in ownership | May 12, 2025 | Insider trade | SEC |
| 8-K · Current report | May 12, 2025 | Meeting outcome | SEC |
| 10-Q · Quarterly report | May 12, 2025 | Quarterly report | SEC |
| 8-K · Current report | May 12, 2025 | Results | SEC |
| SCHEDULE 13G · Big-stake notice | May 12, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 9, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 9, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Apr 22, 2025 | Big-stake notice | SEC |
| UPLOAD · Letter from the SEC | Apr 14, 2025 | Other filings | SEC |
| DRS · Draft registration statement | Apr 8, 2025 | Offer document | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Apr 1, 2025 | Insider trade | SEC |
| 3 · Initial statement of ownership | Apr 1, 2025 | Insider trade | SEC |
| 8-K · Current report | Mar 28, 2025 | Management or board change | SEC |
| DEFA14A · Additional proxy material | Mar 28, 2025 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Mar 28, 2025 | Meeting notice | SEC |
| 10-K · Annual report | Mar 26, 2025 | Annual report | SEC |
| 8-K · Current report | Mar 26, 2025 | Results | SEC |
| 8-K · Current report | Mar 3, 2025 | Results | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 14, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Feb 11, 2025 | Management or board change | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 10, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 7, 2025 | Insider trade | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 4, 2025 | Big-stake notice | SEC |
| SCHEDULE 13D · Big-stake notice | Feb 3, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Jan 30, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 8, 2025 | Big-stake notice | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Jan 2, 2025 | Big-stake notice | SEC |
| 8-K · Current report | Dec 20, 2024 | Material contract | SEC |
| SC 13G · Big-stake notice | Dec 6, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Nov 20, 2024 | Insider trade | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 12, 2024 | Quarterly report | SEC |
| 8-K · Current report | Nov 12, 2024 | Results | SEC |
| SC 13G · Big-stake notice | Nov 8, 2024 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 31, 2024 | Big-stake notice | SEC |
| SCHEDULE 13G · Big-stake notice | Oct 31, 2024 | Big-stake notice | SEC |
| SC 13G · Big-stake notice | Oct 8, 2024 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 4 · Change in ownership | Oct 1, 2024 | Insider trade | SEC |
| 8-K · Current report | Sep 30, 2024 | Material contract | SEC |
| S-8 · Registration statement for employee plans | Sep 27, 2024 | Offer document | SEC |
| 424B4 · Prospectus | Sep 26, 2024 | Offer document | SEC |
| S-1MEF · Registration of more shares for the same offering | Sep 26, 2024 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Sep 26, 2024 | Other filings | SEC |
| 3 · Initial statement of ownership | Sep 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 25, 2024 | Insider trade | SEC |
| 3 · Initial statement of ownership | Sep 25, 2024 | Insider trade | SEC |
This page holds 200 of 229 filings. Open Filings
Cap table
Built by 6ix from Guardian Pharmacy Services, Inc.’s releases
- Common shares
- 63,320,300
- Fully diluted
- 63,320,300
Fully diluted
| Line | Shares |
|---|---|
| Common shares | 63,320,300 |
Share count over time
| Count | Shares |
|---|---|
| Nov 22, 2026 | 63,320,300 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Randall J Lewis Other companies: Simon Property Group, Inc. (Director · Since at least Mar 21, 2023); Elevance Health, Inc. (EVP & Chief Compliance Officer · Feb 16, 2006 – Aug 7, 2009 · Past) | Director · Since at least Sep 25, 2024 |
| Steven D Cosler Other companies: NNN REIT, Inc. (Director · Since at least Aug 19, 2016); Catamaran Corp (USA) (Director · Mar 31, 2008 – Jul 23, 2015 · Past) | Director · Since at least Sep 25, 2024 |
| William E Bindley Other companies: Kite Realty Group Trust (Director · Feb 13, 2006 – May 10, 2023 · Past); Shoe Carnival, Inc. (Director · Jan 2, 2006 – Mar 15, 2012 · Past) | Director · Since at least Sep 25, 2024 |
| Mary Sue Patchett Other companies: Brookdale Senior Living Inc. (Executive Vice President and Chief Operating Officer · Since at least Nov 2, 2015) | Director · Since at least Sep 25, 2024 |
| Bob Weir | SVP, Operations & Regulatory Support · Since at least Nov 4, 2026 |
| Chris Crisafulli | See Remarks · Since at least Apr 1, 2026 |
| Chris Crisafulli | SVP, Payor and Industry Strategy · Since at least Nov 4, 2026 |
| David Brown | SVP, Central Region · Since at least Nov 2, 2026 |
| David Martin | See Remarks · Since at least Apr 1, 2026 |
| David Morris | Chief Operating Officer · Since at least Sep 25, 2024 |
All 35 people
| Person | Seat |
|---|---|
| Douglas Towns | See Remarks · Since at least Apr 1, 2026 |
| Doug Towns | SVP, General Counsel & Senior Compliance Officer · Since at least Nov 4, 2026 |
| Fred Burke | See Remarks, Director · Since at least Sep 25, 2024 |
| Fred Burke | President & CEO · Since at least Sep 28, 2026 |
| Jeffrey Tuch | See Remarks · Since at least Apr 1, 2026 |
| Jeff Tuch | SVP, Purchasing & Pricing Analytics · Since at least Nov 4, 2026 |
| John Ackerman | Director · Since at least Sep 25, 2024 |
| John Saliba | SVP, West Region · Since at least Nov 5, 2026 |
| Kendall Forbes | See Remarks · Since at least Sep 25, 2024 |
| Khristy McClelland | SVP, Southeast Region · Since at least Jun 16, 2026 |
| Marybeth Terry | SVP, East Region · Since at least Sep 1, 2026 |
| Matthew Hopp | Regional Pharmacy President, Georgia · Since at least Nov 5, 2026 |
| Michael Counts | SVP, Midwest Region · Since at least May 14, 2025 |
| Mike Flint | Regional Pharmacy President, Wisconsin · Since at least Nov 4, 2026 |
| Nathan Stauffer | Regional Pharmacy President, Michigan · Since at least Nov 5, 2026 |
| Richard Eakins | Senior Vice President, Sales · Since at least Apr 1, 2026 |
| Rich Eakins | SVP, Sales, Account Management, Marketing · Since at least Sep 28, 2026 |
| Robert Weir | See Remarks · Since at least Apr 1, 2026 |
| Rockford Anderson | SVP, North Central Region · Since at least Nov 5, 2026 |
| Ron Belville | Regional Pharmacy President, California · Since at least Nov 4, 2026 |
| Tanner Corsini | SVP, South Central Region · Since at least Nov 5, 2026 |
| Thomas J Salentine Jr | Director · Since at least Sep 25, 2024 |
| Tom Mullaney | Regional Pharmacy President, Ohio · Since at least Apr 14, 2025 |
| William Franklin Mudd | See Remarks · Since at least Apr 1, 2026 |
| Will Mudd | Chief Financial Officer · Since at least Aug 6, 2026 |
Log in to ask 6ix AI your own questions about Guardian Pharmacy Services, Inc.